Verition Fund Management
KMTS

Verition Fund Management’s Kestra Medical Technologies KMTS Stock Holding History

Verition Fund Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,901
Closed -$371K – 3945
2025
Q1 		$371K Buy
+14,901
New +$342K ﹤0.01% 2758

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Verition Fund Management's KMTS Position: Q2 2025 in Review

Verition Fund Management sold out of Kestra Medical Technologies (KMTS) in Q2 2025, closing a stake of 14,901 shares — an estimated $371K sold.

Verition Fund Management first reported a position in KMTS in Q1 2025 and held it in 1 quarter. The position peaked at $371K in Q1 2025. 73 funds tracked by Wall St. Rank hold KMTS as of Q2 2025.

  • Verition Fund Management reported no remaining Kestra Medical Technologies position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 14,901 Kestra Medical Technologies shares in Q2 2025, an estimated $371K.
  • Verition Fund Management first reported a position in Kestra Medical Technologies in Q1 2025 and held it in 1 quarter.
  • Verition Fund Management's Kestra Medical Technologies position peaked at $371K in Q1 2025.
  • 73 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.